12 - behaviour Flashcards
1
Q
Forms of mental distresses (chronic fear)?
A
- anxiety (aggressivity, restlessness)
- phobia (sounds)
- mania (tail/leg biting)
- depression
2
Q
Most important drugs to modify behaviour?
A
- sedatives (neuroleptics, benzodiazepines)
- antidepressant
- antiepileptics (carbamazepine, phenobarbital)
- artificial pheromones (feliway, felifriend, DAP)
3
Q
Other drugs to modify behaviour?
A
- β-adrenoceptor blocking drugs (propranolol)
- opoid antagonists
- CNS-stimulants
- antihistamines
- hormones
- cerebral vasodilators
- feed supplements (tryptophan)
4
Q
Mention 4 antidepressant
A
- tricyclic antidepressant (TCAs)
- serotonin reuptake inhibitors (SRIs)
- monoamine oxidase inhibitors (MAOIs)
- lithium (narrow, not used)
5
Q
Tricyclic antidepressant (TCAs)
- examples
- mechanism of action
- pharmacokinetics
A
- Amitryptiline, Doxepin, Imipramine
- action: inhibition of serotonin and NA reuptake
- pharma: good oral absorption, high availability, often bound to albumin, cpss 2 -3 weeks, metabolism in liver, urine elimination
6
Q
Tricyclic antidepressant (TCAs)
- side effects
- warning
- indications
A
- side effects: moderate sedation, occasional vomiting, changes in appetite and lethargy, antimuscarinic effects, urinary retention
- warning: patients with cardiovascular dysfunction may experience epilepsy and hypersensitivity
- indications: separation anxiety, feline urine spraying, acral lick dermatitis
7
Q
Serotonin reuptake inhibitors (SRIs)
- examples
- mechanism of action
- pharmacokinetics
A
- Fluoxetine (Prozac), Sertraline (Zoloft)
- action: selective inhibition of serotonin reuptake
- pharma: good oral absorption, high availability, bounded to albumin, metabolism in liver (fluoxetine –> norfluoxetin), elimination half-life 7-9 days
8
Q
Serotonin reuptake inhibitors (SRIs)
- side effects
- warning
- indications
- dose
A
- side effects: occasional vomiting, diarrhea, increased CYP450 activity
- warning: severe hepatic and/or renal impairment - diabets, epilepsy
- indications: aggression, depression, fear (separation, feline urine spraying)
- dose: dogs 1-4 mg/kg bw (1x), cats approx. 4 times less
9
Q
Monoamine oxidase inhibitors (MAOIs)
- examples
- mechanism of action
- pharmacokinetics
A
- selegiline (Jumex)
- action: decreased intracellular metabolism of adrenaline, noradrenaline, prolonged NT action in synapses
- pharma: bad oral absorption, low oral bioavailability, cpss after 3-4 weeks
10
Q
Monoamine oxidase inhibitors (MAOIs)
- side effects
- indications
- dose
A
- side effects: gastrointestinal signs, behavioural changes, excitements
- indications: stereotypes, aggression
- older dogs: changes in cognitive function
- older cats: vocalisation
- dose: 0.5 - 1 mg/kg bw (1x)
11
Q
Benzodiazepines characteristics
A
- sedative, anxiolytic, hypnotic effects
- relative safe drugs
- used for phonophobia, fear induced aggreassion, cat vs- cat aggression
12
Q
Examples of benzodiazepines
A
- Alprozolam (Sanax) - faster onset, shorter action, big interindividual differences (dose)
- Diazepam (Ziapam AUV, Seduxen) - short activity in dogs, longer in cats
- Lorazepam (Loranxil) - in cats, failed depth sensation, appetite, paradoxical reaction
13
Q
How to describe epilepsy?
A
- most common cause of recurrent seizures, where seizures are single events that reoccur with seemingly random frequency. Single seizures can be caused by head injury, fever, reactions to medications, tumours or symptoms of a larger disease
- many different kinds of seizures
- may be caused by hereditary or unknown causes
- described by their symptoms and origin in brain
- tonic-clonic seizures: most commonly associated with epilepsy, generalized seizure affecting the entire brain
- absence seizures - several forms of epilepsy
14
Q
How to describe seizure?
A
- caused by an abnormal high frequency discharge of a group of neurons, starting locally and spreading to affect other parts of the brain
- may be associated with enhanced excitatory transmission, impaired inhibitory transmission or abnormal electrical properties of the affected cells
- the glutamate content in areas surrounding an epileptic focus is often raised
- may be partial or generalised depending on the location and spread of the abnormal neuronal discharge
- the attack may involve mainly motor, sensory or behavioural phenomena
- unconsciousness occurs when the reticular formation is involved
15
Q
Treatment of epilepsy?
A
- monotherapy is preferred if possible
- combination if necessary:
- phenytoin + phenobarbital
- carbamazepine + phenobarbital
- carbamazepine + phenytoin